These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27139372)

  • 21. Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma.
    Matsuo K; Sheridan TB; Mabuchi S; Yoshino K; Hasegawa K; Studeman KD; Im DD; Rosenshein NB; Roman LD; Sood AK
    Gynecol Oncol; 2014 Jun; 133(3):473-9. PubMed ID: 24674832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
    Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
    J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of ER/PR expression in ovarian low-grade serous carcinoma.
    Escobar J; Klimowicz AC; Dean M; Chu P; Nation JG; Nelson GS; Ghatage P; Kalloger SE; Köbel M
    Gynecol Oncol; 2013 Feb; 128(2):371-6. PubMed ID: 23103384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.
    Liu D
    Cell Oncol (Dordr); 2020 Apr; 43(2):321-333. PubMed ID: 31933152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.
    Aleskandarany MA; Abduljabbar R; Ashankyty I; Elmouna A; Jerjees D; Ali S; Buluwela L; Diez-Rodriguez M; Caldas C; Green AR; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Sep; 159(2):215-27. PubMed ID: 27514395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels.
    Hall RE; Lee CS; Alexander IE; Shine J; Clarke CL; Sutherland RL
    Int J Cancer; 1990 Dec; 46(6):1081-7. PubMed ID: 2249895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of androgen receptor expression on clinical characterization of metastatic breast cancer.
    Kim JY; Park K; Lee E; Jung HH; Ahn JS; Im YH; Park WY; Park YH
    Oncotarget; 2017 Jan; 8(5):8693-8706. PubMed ID: 28060723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and progesterone receptors in ovarian cancer.
    Harding M; Cowan S; Hole D; Cassidy L; Kitchener H; Davis J; Leake R
    Cancer; 1990 Feb; 65(3):486-91. PubMed ID: 2297640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased androgen receptor expression in estrogen receptor-positive/progesterone receptor-negative breast cancer.
    García X; Elía A; Galizzi L; May M; Spengler E; Martínez Vázquez P; Burruchaga J; Gass H; Lanari C; Lamb CA
    Breast Cancer Res Treat; 2020 Feb; 180(1):257-263. PubMed ID: 31950383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
    Martins FC; Couturier DL; Paterson A; Karnezis AN; Chow C; Nazeran TM; Odunsi A; Gentry-Maharaj A; Vrvilo A; Hein A; Talhouk A; Osorio A; Hartkopf AD; Brooks-Wilson A; DeFazio A; Fischer A; Hartmann A; Hernandez BY; McCauley BM; Karpinskyj C; de Sousa CB; Høgdall C; Tiezzi DG; Herpel E; Taran FA; Modugno F; Keeney G; Nelson G; Steed H; Song H; Luk H; Benitez J; Alsop J; Koziak JM; Lester J; Rothstein JH; de Andrade JM; Lundvall L; Paz-Ares L; Robles-Díaz L; Wilkens LR; Garcia MJ; Intermaggio MP; Alcaraz ML; Brett MA; Beckmann MW; Jimenez-Linan M; Anglesio M; Carney ME; Schneider M; Traficante N; Pejovic N; Singh N; Le N; Sinn P; Ghatage P; Erber R; Edwards R; Vierkant R; Ness RB; Leung S; Orsulic S; Brucker SY; Kaufmann SH; Fereday S; Gayther S; Winham SJ; Kommoss S; Pejovic T; Longacre TA; McGuire V; Rhenius V; Sieh W; Shvetsov YB; Whittemore AS; Staebler A; Karlan BY; Rodriguez-Antona C; Bowtell DD; Goode EL; Høgdall E; Candido Dos Reis FJ; Gronwald J; Chang-Claude J; Moysich KB; Kelemen LE; Cook LS; Goodman MT; Fasching PA; Crawford R; Deen S; Menon U; Huntsman DG; Köbel M; Ramus SJ; Pharoah PDP; Brenton JD
    Br J Cancer; 2020 Sep; 123(5):793-802. PubMed ID: 32555365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low androgen/progesterone or high oestrogen/androgen receptors ratio in serous ovarian cancer predicts longer survival.
    Gogola-Mruk J; Pietrus M; Piechowicz M; Milian-Ciesielska K; Głód P; Wolnicka-Glubisz A; Szpor J; Ptak A
    Reprod Biol; 2024 Sep; 24(3):100917. PubMed ID: 38970978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen receptor status predicts development of brain metastases in ovarian cancers.
    Mittica G; Senetta R; Scotto G; Aglietta M; Maggiorotto F; Ghisoni E; Genta S; Boldorini R; Manini C; Morra I; Buosi R; Sapino A; Cassoni P; Valabrega G
    Oncotarget; 2017 Jun; 8(25):41143-41153. PubMed ID: 28467804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer.
    Elattar A; Warburton KG; Mukhopadhyay A; Freer RM; Shaheen F; Cross P; Plummer ER; Robson CN; Edmondson RJ
    Gynecol Oncol; 2012 Jan; 124(1):142-7. PubMed ID: 22001143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of steroid hormone receptors in formation and progression of bladder carcinoma: a case-control study.
    Mashhadi R; Pourmand G; Kosari F; Mehrsai A; Salem S; Pourmand MR; Alatab S; Khonsari M; Heydari F; Beladi L; Alizadeh F
    Urol J; 2014 Nov; 11(6):1968-73. PubMed ID: 25433476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival of patients with ovarian cancer. Apart from stage and grade, tumor progesterone receptor content is a prognostic indicator.
    Slotman BJ; Nauta JJ; Rao BR
    Cancer; 1990 Aug; 66(4):740-4. PubMed ID: 2386902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort.
    Elebro K; Borgquist S; Simonsson M; Markkula A; Jirström K; Ingvar C; Rose C; Jernström H
    Clin Cancer Res; 2015 Aug; 21(16):3640-50. PubMed ID: 25904752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer.
    Lyu S; Yu Q; Ying G; Wang S; Wang Y; Zhang J; Niu Y
    Int J Oncol; 2014 Jan; 44(1):229-37. PubMed ID: 24172884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer.
    Mutonga M; Speedy S; Rademaker A; Liu D; Uthe R; Jain S; Gradishar WJ; Flaum L; Santa-Maria CA
    Breast Cancer Res Treat; 2019 Jul; 176(1):95-100. PubMed ID: 30977026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
    Leitao MM; Soslow RA; Nonaka D; Olshen AB; Aghajanian C; Sabbatini P; Dupont J; Hensley M; Sonoda Y; Barakat RR; Anderson S
    Cancer; 2004 Sep; 101(6):1455-62. PubMed ID: 15316901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alcohol Consumption and Risk of Breast Cancer by Tumor Receptor Expression.
    Wang J; Zhang X; Beck AH; Collins LC; Chen WY; Tamimi RM; Hazra A; Brown M; Rosner B; Hankinson SE
    Horm Cancer; 2015 Dec; 6(5-6):237-46. PubMed ID: 26385458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.